Search Results - Schroeder, Kema Marlen

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Targeting autophagy increases the efficacy of proteasome inhibitor treatment in multiple myeloma by induction of apoptosis and activation of JNK

    Targeting autophagy increases the efficacy of proteasome inhibitor treatment in multiple myeloma by induction of apoptosis and activation of JNK by Salimi, Azam, Schroeder, Kema Marlen, Schemionek-Reinders, Mirle, Vieri, Margherita, Maletzke, Saskia, Gezer, Deniz, Masouleh, Behzad Kharabi, Appelmann, Iris

    Published in BMC cancer
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia

    Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia by Maletzke, Saskia, Salimi, Azam, Vieri, Margherita, Schroeder, Kema Marlen, Schemionek, Mirle, Masouleh, Behzad Kharabi, Brümmendorf, Tim H, Koschmieder, Steffen, Appelmann, Iris

    Published in PloS one
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    The Effect of the Proteasome Inhibitor Ixazomib (MLN9708) and UPR Mediated Therapy in Multiple Myeloma Cells and Bone Marrow Niche

    The Effect of the Proteasome Inhibitor Ixazomib (MLN9708) and UPR Mediated Therapy in Multiple Myeloma Cells and Bone Marrow Niche by Salimi, Azam, Schroeder, Kema Marlen, Vieri, Margherita, Brümmendorf, Tim H., Appelmann, Iris, Kharabi, Behzad

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia

    Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia by Saskia Maletzke, Azam Salimi, Margherita Vieri, Kema Marlen Schroeder, Mirle Schemionek, Behzad Kharabi Masouleh, Tim H. Brümmendorf, Steffen Koschmieder, Iris Appelmann

    Published in PloS one
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: